ANGELA FRAUMANE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AMSTERDAM, NY NPI 1821762410

General Payments — all program years on this page

$1,044.03

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 41
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $977.70 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $977.7039

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $285.0612
Acerta Pharma LLC $273.1612
Janssen Pharmaceuticals, Inc $122.461
Novo Nordisk AS $116.995
GlaxoSmithKline, LLC. $65.634
Amgen Inc. $40.532
Astellas Pharma US Inc $32.181
Lilly USA, LLC $22.621
PFIZER INC. $19.071

By program year

Program yearAmountRecords
2023 $66.332
2024 $977.7039

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078103282 Janssen Pharmaceuticals, Inc $122.46 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100237518 Novo Nordisk Inc $25.00 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100261457 Novo Nordisk Inc $23.62 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100360298 Novo Nordisk Inc $23.17 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100434105 Novo Nordisk Inc $23.20 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100530169 Novo Nordisk Inc $22.00 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104329568 AstraZeneca Pharmaceuticals LP $19.94 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104416617 AstraZeneca Pharmaceuticals LP $21.32 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104563496 AstraZeneca Pharmaceuticals LP $23.66 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105207757 AstraZeneca Pharmaceuticals LP $24.85 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105447701 AstraZeneca Pharmaceuticals LP $25.11 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105451463 AstraZeneca Pharmaceuticals LP $23.98 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105467555 AstraZeneca Pharmaceuticals LP $18.76 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105476961 AstraZeneca Pharmaceuticals LP $14.11 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105501784 AstraZeneca Pharmaceuticals LP $19.06 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105747033 AstraZeneca Pharmaceuticals LP $19.73 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105841159 AstraZeneca Pharmaceuticals LP $24.75 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105890722 AstraZeneca Pharmaceuticals LP $37.89 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129120 ABBVIE INC. $20.39 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129122 ABBVIE INC. $11.56 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129124 ABBVIE INC. $14.39 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129126 ABBVIE INC. $14.72 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129128 ABBVIE INC. $9.02 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129130 ABBVIE INC. $18.39 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129132 ABBVIE INC. $13.75 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129134 ABBVIE INC. $17.91 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129136 ABBVIE INC. $17.76 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129138 ABBVIE INC. $6.49 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129140 ABBVIE INC. $16.48 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107129142 ABBVIE INC. $124.20 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115851605 GlaxoSmithKline, LLC. $17.01 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116401547 GlaxoSmithKline, LLC. $13.50 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116423549 GlaxoSmithKline, LLC. $16.99 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116507787 GlaxoSmithKline, LLC. $18.13 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117556361 Amgen Inc. $22.33 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117556363 Amgen Inc. $18.20 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132030097 PFIZER INC. $19.07 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135471145 Lilly USA, LLC $22.62 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139533632 Astellas Pharma US Inc $32.18 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.